'AstraZeneca Cuts 600 US Sales Staff as Savings Drive Kicks In'- Bloomberg
https://www.bloomberg.com/news/articles/2026-11-13/astrazeneca-cuts-600-us-sales-staff-as-savings-drive-kicks-in
AstraZeneca PLC (AZN)
NYSE
$185.08
+$0.59
(+0.32%)
Regular Market
AstraZeneca PLC (AZN) Live Price Chart
Last updated: 2026-11-13 20:23:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
AstraZeneca PLC (AZN) operates in the -- sector and is listed on NYSE. The stock is currently priced at $185.08, with a market capitalization of $285.96B and a P/E ratio of 128.75. Over the past 52 weeks, its price has ranged from $153.41 to $212.71. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$285.96B | |
$184.77 | |
$186.13 | |
$183.96 | |
$184.38 | |
1.44M | |
3.01M | |
128.75 | |
$212.71 | |
$153.41 | |
1.24% | |
12-31 |
AstraZeneca PLC (AZN) Stock Price Today
AstraZeneca PLC (AZN) is currently trading at $185.08 as of 2026-11-13 20:06:40, up 0.32% ($0.59) from the previous close of $184.38
During today's regular trading session, AZN has traded between $183.96 and $186.13, with a trading volume of 1.44M shares. The current price is near the middle of today's range.
AstraZeneca PLC (AZN) 7-Day Stock Price Change
Over the past seven days, AstraZeneca PLC (AZN) moved from $186.85 to $185.08, representing a decline of 0.95% ($1.77).
The stock traded between $181.20 and $192.65 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 2.15 million shares, down versus the previous seven-day period, indicating lower trading activity.
AZN 52-Week Price Position
Position in Range: 53.4%
52W Low$153.41
52W High$212.71
AZN is currently trading at $185.08, placing it 53.4% of the way from its 52-week low of $153.41 to its 52-week high of $212.71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is AstraZeneca PLC (AZN)?
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
AstraZeneca PLC Information
| Employees | 96,100 |
| CEO | Pascal Claude Roland Soriot |
| Founded | 1992 |
| Exchange | NYSE |
| Company Website |
AZN Stock Events
View the latest dividend and stock split events for AstraZeneca PLC.
Dividend | |
|---|---|
| Ex-Dividend Date | Aug 7, 2026 |
| Payment Date | Sep 8, 2026 |
| Dividend Per Share | $0.795 |
AZN News
Latest news related to AstraZeneca PLC and AZN stock.
- BenzingaRead Full Article
- BenzingaRead Full Article
AstraZeneca's Baxfendy Recommended For Approval In EU For Treatment Of Adult Patients Arterial Hypertension Insufficiently Controlled With At Least Two Antihypertensive Medicinal Products
https://news.cision.com/se/astrazeneca/r/baxfendy--baxdrostat--recommended-for-approval-in-the-eu-for-the-treatment-of-adults-with-hypertensi%2Cc4423959
- MassiveRead Full Article
BCMA Targeted Therapies Competitive Landscape Analysis: 100+ Pipeline Therapies Driving Innovation in Therapeutics Segment | DelveInsight
DelveInsight released a comprehensive competitive landscape report on BCMA-targeted therapies, analyzing 100+ pipeline drugs across 80+ companies. The report highlights recent clinical advances including Pfizer's positive Phase III results for ELREXFIO, AbbVie's BLA submission for etentamig, and Gilead's $7.8 billion acquisition of Arcellx to gain control of anito-cel. Key challenges include treatment resistance, relapse, and manufacturing complexity, while the pipeline focuses on improving durability, safety, and accessibility through next-generation approaches.
- MassiveRead Full Article
GLP-1 RAs & Incretin-based Therapies Competitive Landscape Analysis: Key Developments by 200+ Companies Shaping the Treatment Landscape | DelveInsight
DelveInsight released a comprehensive competitive landscape report on GLP-1 receptor agonists and incretin-based therapies, covering 200+ pipeline drugs from 180+ active players. The report highlights approved drugs like MOUNJARO (tirzepatide) and OZEMPIC (semaglutide), with 30+ therapies in late-stage development and 60+ in mid/early stages. Key indications include obesity, type 2 diabetes, and cardiovascular outcomes. Recent developments include positive Phase III results for retatrutide, survodutide, and other dual/triple agonists from major pharmaceutical companies.
Ways to Trade AZN at MEXC
How to Buy AstraZeneca PLC (AZN) Stock on MEXC
Eligible investors can buy real shares of AstraZeneca PLC (AZN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for AZN and Place Your Order
Open the RealStocks trading page and search for AZN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.
Frequently Asked Questions (FAQ)
1.What is AstraZeneca PLC (AZN) stock price today?
AstraZeneca PLC (AZN) is currently trading at $185.08, up 0.32% ($0.59) from the previous close of $184.38. Intraday prices update in real time during regular trading hours.
2.Is AZN stock going up or down today?
As of 2026-11-13 20:06:40, AZN is trading at $185.08, up 0.32% ($0.59) from its previous close of $184.38. The stock has traded between $183.96 and $186.13 during today’s regular session. Past price movements do not guarantee future results.
3.What is AZN pre-market price?
As of 2026-11-13 20:06:40, AZN is trading at $184.17 in pre-market trading, down 0.11% ($0.21) from the previous close of $184.38. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is AZN after-hours price?
As of 2026-11-13 20:06:40, AZN is trading at $185.16 in after-hours trading, up 0.04% ($0.08) from the regular-session close of $185.08. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is AZN stock trading now?
AZN trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does AZN sit relative to its 52-week high and low?
Over the past 52 weeks, AZN has traded between a low of $153.41 and a high of $212.71. At $185.08, the stock is positioned 53.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is AstraZeneca PLC in?
AstraZeneca PLC (AZN) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is AstraZeneca PLC's market capitalization and where is it listed?
AstraZeneca PLC is listed on the NYSE exchange with a market capitalization of $285.96B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is AZN valued in terms of P/E ratio and EPS?
AZN trades at a P/E ratio of 128.75, based on trailing-twelve-month EPS of $1.43. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does AstraZeneca PLC pay a dividend?
AstraZeneca PLC pays an indicated annual cash dividend of $2.30 per share, with a current dividend yield of 1.24% based on the latest share price. Dividend policies are subject to change at the board's discretion.
Explore More US Stocks
Stocks in the Same Sector
Browse other US stocks in the same sector as AstraZeneca PLC
Largest Market Cap
See US stocks with the highest market capitalization
Most Actively Traded
Discover today's most actively traded US stocks
Top Gainers
Browse today's leading gainers in the US stock market
Top 5 Cryptocurrencies
Explore the cryptocurrencies with the highest market capitalization
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AZN, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
AZN Stock Calculator
Estimate the value between AZN shares and USD.
AZN Shares to USD
AZN Shares
AZN
USD
USD
1.00 AZN shares = 185.079 USD
Calculations are estimates based on the latest available price and are for reference only.